RCT-1100

N/A

Report date: 2024/06/28 09:17:56

Base Information

Drug NameRCT-1100
Drug Alias NameRCT1100RCT-1100
ClassificationCell and gene therapy > Gene therapy > mRNA
Mechanisms of ActionDNAI1 protein expression stimulants
TargetsDynein axonemal intermediate chain 1
Therapy Area/IndicationsCiliary Motility Disorders
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesNew ZealandDenmark +[6] 
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesRecode Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesRecode Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsCiliary Motility Disorders
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A